FierceBiotech

Francis Medical collects $80M to carry water vapor ablation for prostate cancer to the FDA

Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...
FierceBiotech

Francis Medical gets FDA green light for water vapor ablation to treat prostate cancer

Francis Medical is heating up with a 510(k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of the prostate, kidneys and bladder. The regulatory go-ahead for its Vanquish ...
WFLA News Channel 8

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...
Hosted on MSN

FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer

Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug Administration (FDA). Vanquish is a transurethral, ultrasound and ...
Star Tribune

How a Minnesota medtech startup with big backers treats prostate cancer with water

Michael Hoey admits he’s terrible at names. He used to call his kids “One, Two and Three.” When naming his startup seeking to treat a common cancer with only a few drops of water, Hoey had his ...
MarketWatch

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish(R) Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

The MarketWatch News Department was not involved in the creation of this content. MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing ...